Submitted by Ian Dick, SLC Industry Liaison, and Jeremy Butler, Research Ethics Officer
Dr. Maha Othman, a professor in SLC’s School of Baccalaureate Nursing, was recently interviewed by Science Norway for an article on COVID-19 vaccines. Drawing on her expertise and extensive research on bleeding disorders and blood clotting, Dr. Othman offered valuable insight into some of the mechanisms that may underlie rare side effects reportedly associated with the Astra Zeneca and Johnson & Johnson vaccines.
Dr. Othman is an internationally recognized researcher on bleeding disorders, with over 95 publications in peer-reviewed journals. Her research interests are focussed on platelet type von Wildebrand disease, thromboeslastography applications, and coagulopathies in cancer, hormonal contraception, and pregnancy.
In addition to her research and her faculty role at SLC, Dr. Othman chairs SLC’s Research Ethics Board and the BScN Scholarship Committee, and she is an adjunct professor in the Department of Biomedical and Molecular Science at Queen’s University. She is also the Chair of the International Scientific Standardization Committee on Women’s Health Issues in Thrombosis and Haemostasis, and she speaks regularly at international conferences.
You can learn more about Dr. Othman and her research by visiting her SLC faculty profile. Read Dr. Othman's interview in the Science Norway article.